Webinars on demand

As more AAV-based gene therapies move towards the clinic, there is a growing need for scalable and cost-effective production processes that maintain virus quality.

The use of adenovirus-associated virus (AAV) vectors in gene therapy is growing.

Analytical Method Lifecycle Management (AMLM) principles require a holistic perspective where method robustness is considered together with process and product variability.

Out of trend (OOT) and out of specification (OOS) results for Microbiology testing are inevitable challenges that every sterile manufacturing environment must face.

Cell therapy logistics is challenged by complex processes, inefficiency, and lack of flexibility to accommodate manufacturing, clinic, and patient needs

Upstream process intensification efforts are becoming mainstream in every biopharma R&D lab and clinical program.

With this webinar we pretend to look at the different sorts of impurities that may occur in pharmaceutical products and discuss current regulations, requirements and control strategies to be followed in order to comply with the current demands.

Join Thermo Fisher Scientific’s drug development and clinical services experts for another Q&A session to hear about the company’s innovation.

Join Thermo Fisher Scientific’s drug development and manufacturing experts for a unique, extended Q&A session and learn how to start navigating the new normal.

The cell and gene therapy regulatory landscape is rapidly evolving. Join this webinar to discover the approaches available to this industry to accelerate the approval of cell and gene therapy products.

Join us for an informative webinar on May 26 at 10am EDT / 4pm CEST as we discuss the advantages of DBcaps®.

This webinar will give viewers the tools they need to initiate a close examination of their methods.